|
|
|
Volumn 23, Issue 4, 2002, Pages 347-349
|
|
Second-line with paclitaxel and carboplatin for recurrent disease following first paclitaxel and platinum compounds in ovarian carcinoma
a
a
a
a
NONE
(Italy)
|
|
Author keywords
Carboplatin; Chemotherapy; Ovarian cancer; Paclitaxel
|
|
Indexed keywords
CARBOPLATIN;
DIPHENHYDRAMINE;
FAMOTIDINE;
PACLITAXEL;
PREDNISONE;
SEROTONIN 3 ANTAGONIST;
ANTINEOPLASTIC AGENT;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CLINICAL ARTICLE;
FEMALE;
HUMAN;
MYALGIA;
NEUROTOXICITY;
OVARY CARCINOMA;
TREATMENT OUTCOME;
VOMITING;
CANCER STAGING;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MIDDLE AGED;
MORTALITY;
OVARY TUMOR;
PALLIATIVE THERAPY;
PATHOLOGY;
TUMOR RECURRENCE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMAN;
INFUSIONS, INTRAVENOUS;
MIDDLE AGE;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PACLITAXEL;
PALLIATIVE CARE;
TREATMENT OUTCOME;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035991033
PISSN: 03922936
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (11)
|
|
References (19)
|
